Skip to main content

Table 3 Overall LVEF of all patients pre-procedure and at the first follow-up (4 months ± 1.9 months after procedure), demonstrating improvement

From: Safety and outcomes analysis: transcatheter implantation of autologous angiogenic cell precursors for the treatment of cardiomyopathy

Variable

n

Mean

SD

95% conf. interval

Pre-treatment

52

28.6

10.4

25.7–31.5

Post-treatment

52

33.2

12.0

29.9–36.6

Difference

52

4.6

9.6

− 7.3– − 1.9

t = − 3.4607

    

p < 0.001

    
  1. Paired t-test
Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512